FG
BMY icon

Fairman Group’s Bristol-Myers Squibb BMY Stock Holding History

Fairman Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Hold
718
– – 0.03% 110
2026
Q1 		$43.5K Hold
718
– – 0.04% 102
2025
Q4 		$38.7K Hold
718
– – 0.03% 111
2025
Q3 		$32.4K Hold
718
– – 0.03% 120
2025
Q2 		$33.2K Sell
718
-101
-12% -$4.96K 0.03% 115
2025
Q1 		$46.3K Hold
819
– – 0.04% 99
2024
Q4 		$46.3K Hold
819
– – 0.04% 109
2024
Q3 		$42.4K Hold
819
– – 0.04% 117
2024
Q2 		$34K Hold
819
– – 0.03% 127
2024
Q1 		$44.4K Hold
819
– – 0.04% 105
2023
Q4 		$42K Buy
+819
New +$43K 0.04% 114

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fairman Group's BMY Position: Q2 2026 in Review

Fairman Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 718 shares worth $41.4K. The position accounts for 0.03% of the portfolio, ranked #110.

Fairman Group first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $46.3K in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Fairman Group held 718 shares of Bristol-Myers Squibb worth $41.4K as of Q2 2026.
  • Fairman Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.03% of Fairman Group's portfolio in Q2 2026, its #110 holding.
  • Fairman Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Bristol-Myers Squibb position peaked at $46.3K in Q1 2025.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.